Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy

被引:45
作者
Chatterjee, Subhajit [1 ]
Sinha, Saptarshi [1 ]
Kundu, Chanakya Nath [1 ]
机构
[1] Deemed Univ, Kalinga Inst Ind Technol KIIT, Sch Biotechnol, Canc Biol Div, Campus 11, Bhubaneswar 751024, Odisha, India
关键词
Nectin-4; Cancer; Cancer stemness; Angiogenesis; Metastasis; Therapeutic strategies; VEDOTIN PLUS PEMBROLIZUMAB; ENFORTUMAB VEDOTIN; MEASLES-VIRUS; TRANS-INTERACTIONS; PROGNOSTIC ROLE; PHASE-III; V-DOMAIN; C-SRC; EXPRESSION; RECEPTOR;
D O I
10.1016/j.ejphar.2021.174516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4.
引用
收藏
页数:20
相关论文
共 88 条
  • [1] The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma
    Athanassiadou, Anna Maria
    Patsouris, Efstratios
    Tsipis, Angelos
    Gonidi, Maria
    Athanassiadou, Pauline
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (01) : 26 - 33
  • [2] Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
    Bednova, Olga
    Leyton, Jeffrey V.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 25
  • [3] NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach
    Bekos, Christine
    Muqaku, Besnik
    Dekan, Sabine
    Horvat, Reinhard
    Polterauer, Stephan
    Gerner, Christopher
    Aust, Stefanie
    Pils, Dietmar
    [J]. CANCERS, 2019, 11 (05)
  • [4] BLUMING AZ, 1971, LANCET, V2, P105
  • [5] Nectin-1 Binds and Signals through the Fibroblast Growth Factor Receptor
    Bojesen, Kirsten B.
    Clausen, Ole
    Rohde, Kristian
    Christensen, Claus
    Zhang, Lanjun
    Li, Shizhong
    Kohler, Lene
    Nielbo, Steen
    Nielsen, Janne
    Gjorlund, Michelle D.
    Poulsen, Flemming M.
    Bock, Elisabeth
    Berezin, Vladimir
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) : 37420 - 37433
  • [6] Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4
    Boylan, Kristin L. M.
    Manion, Rory D.
    Shah, Heena
    Skubitz, Keith M.
    Skubitz, Amy P. N.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 16
  • [7] The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
    Boylan, Kristin L. M.
    Buchanan, Petra C.
    Manion, Rory D.
    Shukla, Dip M.
    Braumberger, Kelly
    Bruggemeyer, Cody
    Skubitz, Amy P. N.
    [J]. ONCOTARGET, 2017, 8 (06) : 9717 - 9738
  • [8] Mutations in PVRL4, Encoding Cell Adhesion Molecule Nectin-4, Cause Ectodermal Dysplasia-Syndactyly Syndrome
    Brancati, Francesco
    Fortugno, Paola
    Bottillo, Irene
    Lopez, Marc
    Josselin, Emmanuelle
    Boudghene-Stambouli, Omar
    Agolini, Emanuele
    Bernardini, Laura
    Bellacchio, Emanuele
    Iannicelli, Miriam
    Rossi, Alfredo
    Dib-Lachachi, Amina
    Stuppia, Liborio
    Palka, Giandomenico
    Mundlos, Stefan
    Stricker, Sigmar
    Kornak, Uwe
    Zambruno, Giovanna
    Dallapiccola, Bruno
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 87 (02) : 265 - 273
  • [9] Bruce JY, 2020, J CLIN ONCOL, V38
  • [10] Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
    Challita-Eid, Pia M.
    Satpayev, Daulet
    Yang, Peng
    An, Zili
    Morrison, Karen
    Shostak, Yuriy
    Raitano, Arthur
    Nadell, Rossana
    Liu, Wendy
    Lortie, Dawn Ratay
    Capo, Linnette
    Verlinsky, Alla
    Leavitt, Monica
    Malik, Faisal
    Avina, Hector
    Guevara, Claudia I.
    Dinh, Nick
    Karki, Sher
    Anand, Banmeet S.
    Pereira, Daniel S.
    Joseph, Ingrid B. J.
    Donate, Fernando
    Morrison, Kendall
    Stover, David R.
    [J]. CANCER RESEARCH, 2016, 76 (10) : 3003 - 3013